Description
Overview
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist peptide (also referenced in the literature as LY3437943), supplied here strictly for laboratory research use. This kit contains 10 vials at a nominal 30 mg fill each (300 mg total peptide content per kit).
Technical Specifications
| CAS Number | 2381089-83-2 |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight | 4731.33 g/mol |
| Appearance | White lyophilized powder |
| Nominal Fill | 30 mg / vial — 10 vials / kit (300 mg total) |
Batch Certificate of Analysis
Every batch we sell is independently lab-tested before listing, via a third-party blind test that confirms both identity and purity. The figures below are from the current batch’s report — not marketing estimates.
| Identified Compound | Retatrutide (confirmed against a blind panel including Semaglutide, Tirzepatide, Retatrutide) |
| Verified Content | 31.07 mg (tested vial) |
| Verified Purity | 99.693% |
| Testing Laboratory | Janoshik Analytical |
| Task Number | #225885 |
| Analysis Conducted | September 2, 2026 |
View the independently verifiable lab report
Storage & Handling
Ship and store lyophilized powder at -20°C. Reconstitute with bacteriostatic or sterile water immediately before use; once reconstituted, keep refrigerated at 2–8°C and use promptly. Avoid repeated freeze-thaw cycles and prolonged light exposure.
Research Use Only
This product is sold exclusively for in-vitro laboratory and preclinical research use by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease. Not for human consumption.
Reviews
There are no reviews yet.